<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01106560</url>
  </required_header>
  <id_info>
    <org_study_id>P01.004.12 rev.01</org_study_id>
    <nct_id>NCT01106560</nct_id>
  </id_info>
  <brief_title>A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement</brief_title>
  <official_title>A Single Centre Prospective Randomised Controlled Clinical Trial Comparing Total Hip Arthroplasty Performed Either Through a Posterior Approach or a Direct Anterior Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <brief_summary>
    <textblock>
      This is a single-centre, randomised, prospective clinical follow-up study to evaluate&#xD;
      clinical outcome and gait analysis after total hip arthroplasty using the standard&#xD;
      postero-lateral approach or the minimally invasive anterior approach.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare gait kinematics and the return to normalization of gait in patients that have undergone a THA via the direct anterior approach vs. the posterior approach</measure>
    <time_frame>on average up to 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of patient using the Harris Hip Score</measure>
    <time_frame>pre-op and 6 weeks, 6 months, 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the improvement in quality of life and joint movement using the EuroQol-5D Score</measure>
    <time_frame>pre-op, 1 year post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patient's level of activity using the UCLA score</measure>
    <time_frame>pre-op and 6 weeks, 6 months, 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological evaluation to assess the fixation and stability of femoral and acetabular components</measure>
    <time_frame>pre-op and 6 weeks, 6 months, 1 year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength Testing</measure>
    <time_frame>6 weeks, 6 months and 1y after surgery</time_frame>
    <description>Muscle strength will be assessed using the MIE digital myometer (from patient #50 to patient #100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI evaluation</measure>
    <time_frame>preop-1y after surgery</time_frame>
    <description>A MRI examination will be used to detect any damage in the hip musculature and tendons (from patient #50 to patient #100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of gait kinematics</measure>
    <time_frame>6 weeks, 12 weeks and 6 months</time_frame>
    <description>Comparison gait analysis Anterior vs Posterior groups at fixed time point (from patient #50 to patient # 100)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Anterior Approach Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(AMIS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior Approach Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(Posterior)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally Invasive Anterior Approach</intervention_name>
    <description>Anterior minimally invasive surgery (AMIS)</description>
    <arm_group_label>Anterior Approach Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard postero-lateral approach</intervention_name>
    <arm_group_label>Posterior Approach Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females aged 18-75 years at time of surgery.&#xD;
&#xD;
          -  Those presenting with primary or secondary osteoarthritis and/or rheumatoid arthritis&#xD;
             of the hip.&#xD;
&#xD;
          -  Those deemed capable of giving informed consent, understanding the aims of the study&#xD;
             and expressing willingness to comply with the post-operative review programme.&#xD;
&#xD;
          -  Patients who signed the study consent form prior to surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women or women who plan to conceive in the future.&#xD;
&#xD;
          -  Those whose prospects for a recovery to independent mobility would be compromised by&#xD;
             known coexistent, medical problems.&#xD;
&#xD;
          -  Those already treated by with a Total Hip Replacement (THR) (i.e. requiring a revision&#xD;
             hip replacement).&#xD;
&#xD;
          -  Those with co-existent ipsilateral knee disease or back problems&#xD;
&#xD;
          -  Muscle contracture around the hip joint&#xD;
&#xD;
          -  Individuals who have undergone organ transplant.&#xD;
&#xD;
          -  Those with a known co-existent medical condition where death is anticipated within&#xD;
             five years due to the pre-existing medical condition.&#xD;
&#xD;
          -  Individuals who have had a THR on the contra-lateral side within the 6 months.&#xD;
&#xD;
          -  Individuals who have undergone a THR on the contralateral side and whose outcome is&#xD;
             considered unsatisfactory or not good. An unsatisfactory or poor result is defined as&#xD;
             achieving a total UCLA score (including activity) &lt; 16 points.&#xD;
&#xD;
          -  Individuals requiring bilateral hip replacement.&#xD;
&#xD;
          -  Individuals whose body mass index (BMI; kg/m2) &gt;35.&#xD;
&#xD;
          -  Individuals with active or suspected infection or sepsis.&#xD;
&#xD;
          -  Individuals with renal failure and/or renal insufficiency.&#xD;
&#xD;
          -  Patients with severe forms of developmental dysplasia of the hip (DDH): Crowe types&#xD;
             II, III, IV.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard E Field, PhD FRCS(Orth)</last_name>
    <role>Principal Investigator</role>
    <affiliation>British Orthopaedic Association</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Elective Orthopaedic Centre (EOC)</name>
      <address>
        <city>Epsom</city>
        <zip>KT18 7EG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>April 15, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2010</study_first_posted>
  <last_update_submitted>April 11, 2016</last_update_submitted>
  <last_update_submitted_qc>April 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

